Showing results (1861-1870 of 1,934) with videos related to
Sort By:
Pageof 194
Science Translational Medicine|February 22, 2023
Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2Priya Bhardwaj, Neil M Iyengar, Heba Zahid, et al.Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.Nature Communications|April 18, 2023
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancerJodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, et al.Human Reproduction (Oxford, England)|May 29, 2026
ABHD2 activity is not required for the non-genomic action of progesterone on human spermMadison Edwards, Alexandra Amaral, Eve M Carter, et al.Proceedings of the National Academy of Sciences of the United States of America|July 22, 2020
Phosphoprotein-based biomarkers as predictors for cancer therapyAngela M Carter, Chunfeng Tan, Karine Pozo, et al.MMWR Supplements|July 9, 2016
Implementing an Ebola Vaccine Study - Sierra LeoneMarc-Alain Widdowson, Stephanie J Schrag, Rosalind J Carter, et al.Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 24, 2024
Risk Factors for Hospital Readmission Following Noncardiac Surgery: International Cohort StudyMichael H McGillion, Flavia K Borges, David Conen, et al.MMWR. Morbidity and Mortality Weekly Report|March 21, 2024
Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic - United States, 2019-2021Samantha L Williams, Dallas J Smith, Kaitlin Benedict, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.Pageof 194